Spyre Therapeutics to Participate in Upcoming November Investor Conferences
Spyre Therapeutics (NASDAQ: SYRE) announced that management will participate in three investor conferences in November 2025: the Guggenheim 2nd Annual Healthcare Innovation Conference in Boston on Nov 10, 2025 at 10:00 am ET, the Stifel 2025 Healthcare Conference in New York on Nov 11, 2025 at 8:40 am ET, and the Jefferies Global Healthcare Conference in London on Nov 19, 2025 at 8:00 am GMT. Live audio webcasts and replays will be available on the company’s investor events website at https://ir.spyre.com/events-and-presentations.
Spyre Therapeutics (NASDAQ: SYRE) ha annunciato che la direzione parteciperà a tre conferenze per investitori a novembre 2025: la Guggenheim 2ª Conferenza Annuale sull'Innovazione nel Settore Sanitario a Boston il 10 novembre 2025 alle ore 10:00 ET, la Stifel 2025 Healthcare Conference a New York l'11 novembre 2025 alle ore 08:40 ET, e la Jefferies Global Healthcare Conference a Londra il 19 novembre 2025 alle ore 08:00 GMT. Le trasmissioni audio in diretta e le repliche saranno disponibili sul sito degli eventi per investitori dell’azienda all’indirizzo https://ir.spyre.com/events-and-presentations.
Spyre Therapeutics (NASDAQ: SYRE) anunció que la dirección participará en tres conferencias para inversionistas en noviembre de 2025: la Conferencia de Innovación en Salud Guggenheim 2ª Anual en Boston el 10 de noviembre de 2025 a las 10:00 a. m. ET, la Conferencia de Salud 2025 de Stifel en Nueva York el 11 de noviembre de 2025 a las 8:40 a. m. ET, y la Conferencia Global de Salud de Jefferies en Londres el 19 de noviembre de 2025 a las 8:00 a. m. GMT. Las transmisiones de audio en vivo y las repeticiones estarán disponibles en el sitio web de eventos para inversores de la compañía en https://ir.spyre.com/events-and-presentations.
Spyre Therapeutics (NASDAQ: SYRE)가 2025년 11월에 세 차례의 투자자 컨퍼런스에 경영진이 참여할 것이라고 발표했습니다: 보스턴에서 열리는 구겐하임 2nd Annual Healthcare Innovation Conference, 2025년 11월 10일 동부표준시 오후 10:00, 뉴욕에서 열리는 Stifel 2025 Healthcare Conference, 2025년 11월 11일 동부표준시 오전 8:40, 런던에서 열리는 Jefferies Global Healthcare Conference, 2025년 11월 19일 GMT 오전 8:00에 개최됩니다. 생중계 오디오 웹캐스트와 재생은 회사의 투자자 이벤트 웹사이트 https://ir.spyre.com/events-and-presentations에서 이용 가능합니다.
Spyre Therapeutics (NASDAQ: SYRE) a annoncé que la direction participera à trois conférences pour investisseurs en novembre 2025: la Guggenheim 2nd Annual Healthcare Innovation Conference à Boston le 10 novembre 2025 à 10h00 ET, la Stifel 2025 Healthcare Conference à New York le 11 novembre 2025 à 8h40 ET, et la Jefferies Global Healthcare Conference à Londres le 19 novembre 2025 à 8h00 GMT. Les webcasts audio en direct et les replays seront disponibles sur le site des événements investisseurs de l’entreprise à l’adresse https://ir.spyre.com/events-and-presentations.
Spyre Therapeutics (NASDAQ: SYRE) gab bekannt, dass das Management an drei Investorenkonferenzen im November 2025 teilnehmen wird: die Guggenheim 2nd Annual Healthcare Innovation Conference in Boston am 10. November 2025 um 10:00 Uhr ET, die Stifel 2025 Healthcare Conference in New York am 11. November 2025 um 08:40 Uhr ET, und die Jefferies Global Healthcare Conference in London am 19. November 2025 um 08:00 Uhr GMT. Live-Audio-Webcasts und Wiederholungen stehen auf der Investor-Event-Website des Unternehmens unter https://ir.spyre.com/events-and-presentations zur Verfügung.
Spyre Therapeutics (NASDAQ: SYRE) أعلنت أن الإدارة ستشارك في ثلاث مؤتمرات للمستثمرين في نوفمبر 2025: مؤتمر Guggenheim الثاني للابتكار في الرعاية الصحية في بوسطن يوم 10 نوفمبر 2025 الساعة 10:00 صباحاً بتوقيت شرق الولايات المتحدة، ومؤتمر Stifel للرعاية الصحية 2025 في نيويورك يوم 11 نوفمبر 2025 الساعة 8:40 صباحاً بتوقيت شرق الولايات المتحدة، ومؤتمر Jefferies Global Healthcare Conference في لندن يوم 19 نوفمبر 2025 الساعة 08:00 صباحاً بتوقيت غرينتش. ستتوفر البثوص الصوتية المباشرة وإعادة التشغيل على موقع أحداث الشركة للمستثمرين على العنوان https://ir.spyre.com/events-and-presentations.
Spyre Therapeutics (NASDAQ: SYRE)宣布管理层将参加三场2025年11月的投资者会议：在波士顿举行的Guggenheim 2nd Annual Healthcare Innovation Conference，于2025年11月10日东部时间上午10:00；在纽约举行的Stifel 2025 Healthcare Conference，于2025年11月11日东部时间上午8:40；以及在伦敦举行的Jefferies Global Healthcare Conference，于2025年11月19日GMT上午8:00。现场音频网络广播和回放将可在公司投资者活动网站 https://ir.spyre.com/events-and-presentations 上获取。
- None.
- None.
WALTHAM, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (“IBD”) and rheumatic diseases, today announced that management will participate in the following upcoming investor conferences:
Event: Guggenheim 2nd Annual Healthcare Innovation Conference - Boston
Date: Monday, November 10, 2025
Fireside Time: 10:00 am ET
Event: Stifel 2025 Healthcare Conference – New York
Date: Tuesday, November 11, 2025
Fireside Time: 8:40 am ET
Event: Jefferies Global Healthcare Conference - London
Date: Wednesday, November 19, 2025
Fireside Time: 8:00 am GMT
Live audio webcasts and replays of these events will be available on the Spyre investor events website at https://ir.spyre.com/events-and-presentations.
About Spyre Therapeutics
Spyre Therapeutics is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (“IBD”) and rheumatic diseases. Spyre's pipeline includes investigational extended half-life antibodies targeting α4β7, TL1A, and IL-23.
For more information, visit Spyre's website at www.spyre.com.
For Investors:
Eric McIntyre, Spyre Therapeutics
VP of Finance and Investor Relations
Eric.mcintyre@spyre.com
FAQ
When will Spyre Therapeutics (SYRE) present at the Guggenheim Healthcare Innovation Conference?
How can investors listen to the Spyre (SYRE) presentations in November 2025?
What time is Spyre Therapeutics (SYRE) scheduled to speak at the Stifel 2025 Healthcare Conference?
Does Spyre (SYRE) have a presentation at the Jefferies Global Healthcare Conference in London?
Will Spyre (SYRE) provide replays of its November 2025 investor event presentations?
